酒精室间隔消融治疗梗阻性肥厚型心肌病:支持性意见
本文评述酒精室间隔消融(ASA)治疗梗阻性肥厚型心肌病二十年后的地位。系统回顾长期随访的对比研究显示,ASA与室间隔心肌切除术的(流产)心脏性猝死及死亡率均较低,但ASA的再干预和起搏器植入率仍高于手术。建议将ASA集中于高手术量中心、多学科团队筛选患者、使用(三维)心肌超声造影选择室间隔支及适量酒精以改善结局。
要点
- ASA与室间隔心肌切除术的长期(流产)心脏性猝死及死亡率相似,消融瘢痕致心律失常风险被高估。
- ASA后再干预和起搏器植入率仍高于室间隔心肌切除术,是当前需重点降低的指标。
- 改进方向包括:高手术量中心开展、多学科团队筛选、心肌超声造影选支及适量酒精。
核心结论
- ASA治疗梗阻性肥厚型心肌病二十年之际,消融瘢痕的致心律失常性被过度强调,长期(流产)心脏性猝死及死亡率与室间隔心肌切除术相似。
研究设计与样本
- 系统回顾所有长期随访对比ASA与室间隔心肌切除术的研究。
主要发现
- 对比研究显示,ASA与室间隔心肌切除术的(流产)心脏性猝死及死亡率均较低。
- ASA后的再干预率和起搏器植入率仍高于室间隔心肌切除术,部分因ASA受间隔穿支路径限制。
临床怎么用
- ASA应限于高手术量的肥厚型心肌病卓越中心开展。
- 使用多学科心脏团队改善患者选择。
- 采用(三维)心肌超声造影选择正确的间隔(亚)支,并使用适量酒精进行ASA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Twenty years after the introduction of alcohol septal ablation (ASA) for the treatment of obstructive hypertrophic cardiomyopathy, the arrhythmogenicity of the ablation scar appears to be overemphasized. When systematically reviewing all studies comparing ASA with myectomy with long-term follow-up, (aborted) sudden cardiac death and mortality rates were found to be similarly low. The focus should instead shift toward lowering the rate of reinterventions and pacemaker implantations following ASA because, in this area, ASA still seems inferior to myectomy. Part of the reason for this difference is that ASA is limited by the route of the septal perforators, whereas myectomy is not. Improvement may be achieved by: 1) confining ASA to hypertrophic cardiomyopathy centers of excellence with high operator volumes; 2) improving patient selection using multidisciplinary heart teams; 3) use of (3-dimensional) myocardial contrast echocardiography for selecting the correct septal (sub)branch; and 4) use of appropriate amounts of alcohol for ASA.
引用
- Liebregts M, Vriesendorp PA, Ten Berg JM, et al. Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Endorsement. J Am Coll Cardiol. 2017. PMID: 28728694. doi:10.1016/j.jacc.2017.02.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。